Cargando…
Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol
INTRODUCTION: Targeted therapy directed at specific molecular alterations is already creating a shift in the treatment of cancer patients. Malignant gliomas commonly overexpress the oncogenes EGFR and PDGFR and contain mutations and deletions of the tumor suppressor genes PTEN and TP53. Some of thes...
Autores principales: | Fonseca, Clovis Orlando da, Linden, Rafael, Futuro, Débora, Gattass, Cerli Rocha, Quirico-Santos, Thereza |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Birkhäuser-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778682/ https://www.ncbi.nlm.nih.gov/pubmed/18726148 http://dx.doi.org/10.1007/s00005-008-0027-0 |
Ejemplares similares
-
Perillyl alcohol: Dynamic interactions with the lipid bilayer and implications for long-term inhalational chemotherapy for gliomas
por: da Fonseca, Clovis Orlando, et al.
Publicado: (2016) -
Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
por: Chen, Thomas C., et al.
Publicado: (2018) -
Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy
por: Santos, Juliana Guimaraes, et al.
Publicado: (2020) -
Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism
por: Faria, Giselle M., et al.
Publicado: (2020) -
Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients with Brain Tumors under Perillyl Alcohol-Based Therapy
por: Faria, Giselle, et al.
Publicado: (2018)